The Parkinson's disease sleep scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 6, 2002, Pages 629-635

  Chaudhuri, K Ray ^a   Pal, S ^a   DiMarco, A ^c   Whately Smith, C ^h   Bridgman, K ^f   Mathew, R ^c   Pezzela, F R ^e   Forbes, A ^b   Hogl B ^g   Trenkwalder, C ^d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Pharmacia Limited   (United Kingdom)

^g MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; NIGHT SLEEP; PARKINSON DISEASE; PARKINSON DISEASE SLEEP SCALE; PRIORITY JOURNAL; RELIABILITY; SLEEP DISORDER; SYMPTOMATOLOGY; TEAMWORK; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PARKINSON DISEASE; PATIENT CARE TEAM; PSYCHOMETRICS; QUALITY OF LIFE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SLEEP DISORDERS;

EID: 0036901193     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.6.629     Document Type: Article

References (33)

1. Lees AJ, Blackburn, NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;6:512-19.
2. Askenasy JJM. Sleep in Parkinson's disease. Acta Neurol Scand 1993;87:167-70.
3. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: Parkinson's disease. Neurology 2002;58:341-6.
4. Lang AE, Hobson DE, Martin W, et al. Excessive daytime sleepiness and sudden onset sleep in Parkinson's disease: A survey from 18 Canadian Movement Disorders Clinics [abstract]. Neurology 2001;56(suppl 3):A307.
5. Kales A, Ansel RD, Markham CH, et al. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharm Ther 1971;12:397-406.
6. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-93.
7. Ray Chaudhuri K, Pal S, Bridgman K, et al. Achieving 24-hr control of Parkinson's disease symptoms; use of objective measures to improve nocturnal disability. Eur Neurol 2001;46(S1):3-10.
8. Reuter I, Ray Chaudhuri K. The management of nocturnal disabilities in Parkinson's disease. In: Tod D, ed. NAFP Official Yearbook. London: Scorpio Publishing, 1998:311-14.
9. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14:540-5.
10. Arnulf I, Konofal E, Merino-Andreau M, et al. Is excessive daytime sleepiness in Parkinson's disease related to poor sleep quality? An objective study of 47 patients [abstract]. Neurology 2001;56(suppl 3):A307.
11. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, et al, eds. Recent Developments in Parkinson's Disease. Florham Park: Macmillan Healthcare Information, 1987:153-63.
12. Ray Chaudhuri K, Pal S, Trenkwalder C, et al. Development of a novel scale for assessment of nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:281.
13. Addington-Hall J, Kalra L. Who should measure quality of life? BMJ 2001;322:1417-20.
14. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. New York: John Wiley, 2000.
15. Holm S. A simple sequentially rejective Bonferri test procedure. Scand J Stat 1979;6:65-70.
16. Tan EK, Lum SY, Fook Chong SMC, et al. Evaluation of somnolence in Parkinson's disease: Comparison with age and sex-matched controls. Neurology 2002;3:465-8.
17. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: An integral part of PD. Neurology 2002;58:1019-24.
18. Pal S, DiMarco A, Prezzella FR, et al. Identification of a syndrome of nocturnal restlessness in Parkinson's disease using a novel visual analogue sleep scale. J Neurol Neurosurg Psychiatry (in press).
19. Ray Chaudhuri K, Bhattacharya K, Agapito C, et el. The use of cabergoline in nocturnal parkinsonian disabilities causing sleep disruption: A parallel study with controlled release levodopa. Eur J Neurol 1999;6(suppl 5):S11-15.
20. Marsden CD. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa. Drugs 1998;55(suppl 1):17-22.
21. Reuter I, Ellis CM, Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999;100:163-7.
22. Ghatani T, Agapito C, Bhattacharya K, et al. Comparative audit of pergolide and cabergoline therapy in the treatment of nocturnal "off" periods causing sleep disruption in Parkinson''s disease. Eur J Neurol 2001;8(suppl 1):8-11.
23. Van der Kechove, Jacquy J, Garce M, et al. Sustained-release levodopa in parkinsonian patients with nocturnal disturbances. Acta Neurol Belg 1993;93:32-9.
24. Hogl B, Rothdach A, Wetter TC, et al. Effects of cabergoline on sleep and morning motor performance in patients with Parkinson's disease. Eur J Neurol 1999;6 (suppl 5):S25-8.
25. Arnulf I, Bejjani BP, Garma L, el al. Improvement of sleep architecture with subthalamic nucleus stimulation. Neurology 2001;55:1732-4.
26. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community based study. Mov Disord 1999;14:922-7.
27. Ondo WG, Voung KV, Khan H, et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001;57:1392-6.
28. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52:1908-10.
29. Rye DB, Bliwise DL, Dihenia B, et al. Fast track: Daytime sleepiness and other sleep disorders in Parkinson's disease. J Sleep Res 2000;9:63-9.
30. Rascol O, Ferreira JJ, Desboeuf K, et al. Sleep disruption, daytime somnolence, and "sleep attacks" in Parkinson's disease: A clinical survey in PD patients and age-matched healthy volunteers. Neurology 2001;56(suppl 3):A212.
31. Kryger MH, Roth, T, Dement WC. Daytime sleepiness and alertness. In: Roth T, Roehrs TA, Carskadon MA, et al, eds. Principles and Practice of Sleep Medicine. Philadelphia: WB Saunders, 1994:40-9.
32. Ray Chaudhuri K, Pal S, Forbes A, et al. Does nocturnal sleep disturbance contribute to excessive daytime sleepiness in Parkinson's disease [abstract]. J Neurol Sci 2001;5395:P1162.
33. Stepanski J, Lamphere J, Badia P, et al. Sleep fragmentation and daytime sleepiness. Sleep 1984;7:18-26.